Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Melanoma 1Liver Neoplasms 1Gliosarcoma 1Glioblastoma 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Molecular Targeted Therapy × Clear all
NCT07204262 2025-10-02

Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma

Shenzhen Third People's Hospital

Completed
379 enrolled
Gastrointestinal

Liver Neoplasms

NCT03020017 2022-08-26

NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery

Northwestern University

Phase EARLY_PHASE1 Completed
8 enrolled 11 charts
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT02094872 2020-01-02

Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic

Yale University

Phase 2 Completed
49 enrolled 8 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡